TrialScientific reports2021

The effect of trichlormethiazide in autosomal dominant polycystic kidney disease patients receiving tolvaptan: a randomized crossover controlled trial.

Kiyotaka Uchiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.